| Gene symbol | FOLH1 | Synonyms | FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP | Type of gene | protein-coding | |
| Chromosome | 11 | Map location | 11p11.12 | dbXrefs | Entrez:2346 MIM:600934 HGNC:HGNC:3788 Ensembl:ENSG00000086205 AllianceGenome:HGNC:3788 | |
| Description | folate hydrolase 1 | |||||
| GTO ID | GTC2296 |
| Trial ID | NCT04249947 |
| Disease | Prostatic Adenoma | Salivary Gland Cancer | Urogenital Neoplasm | Salivary Duct Carcinoma | Prostate Cancer | Adenoid Cystic Carcinoma | Mucoepidermoid Carcinoma | Castration-Resistant Prostate Carcinoma | Acinic Cell Tumor | Male Genital Neoplasm | Prostatic Disease |
| Altered gene | PSMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | P-PSMA-101 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) |
| Year | 2020 |
| Country | United States |
| Company sponsor | Poseida Therapeutics, Inc. |
| Other ID(s) | P-PSMA-101-001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||